In vitroActivation of Mononuclear Cells by Two Probiotics:Lactobacillus paracaseiI 1688,Lactobacillus salivariusI 1794, and their Mixture (PSMIX)
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 36 (4) , 413-421
Abstract
Background: Most studies on probiotics have described their effects on the human immune system after ingestion of LAB, but little is known about their effect on in vitro stimulation of human immune cells. Aim of the study: Evaluate the “in vitro” activity of Lactobacillus paracasei (I 1688), Lactobacillus salivarius (I 1794), and a commercial mix of the two (PSMIX, Proge Farm), on immune cells from healthy individuals. Materials: Two probiotic strains, Lactobacillus salivarius (I 1794; Proge Farm, Italy) and Lactobacillus paracasei (I 1688; Proge Farm, Italy), which are contained in the functional food ENTEROBACILLI, were evaluated for their ability to stimulate peripheral blood mononuclear cells and modulate surface phenotype and cytokine production. Results: All subjects responded to the bacteria, with different levels of response. The cell populations that showed a significant percent increase were CD4+/CD25+ cells (T-helper activated regulatory cells), CD8+/CD25+ (T-suppressor/cytotoxic activated cells), and CD16+/CD56+ (NK cells) (pin vitro production significantly increased with exposure to probiotics (pLactobacillus paracasei and Lactobacillus salivarius are capable of inducing a specific immune response that may be useful in the clinical setting for improving innate and adaptive immune responses.Keywords
This publication has 22 references indexed in Scilit:
- Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transportGut, 2004
- Assessment of the Persistence in the Human Intestinal Tract of Two Probiotic Lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688Microbial Ecology in Health and Disease, 2002
- Can Immunoregulatory Lactic Acid Bacteria Be Used as Dietary Supplements to Limit Allergies?International Archives of Allergy and Immunology, 2001
- Toll of allergy reduced by probioticsThe Lancet, 2001
- Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trialThe Lancet, 2001
- Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trialBMJ, 2001
- Toll-like receptors in the induction of the innate immune responseNature, 2000
- Lactobacilli and Streptococci Activate NF-κB and STAT Signaling Pathways in Human MacrophagesThe Journal of Immunology, 2000
- Activation of Human Peripheral Blood Mononuclear Cells by Nonpathogenic Bacteria In Vitro: Evidence of NK Cells as Primary TargetsInfection and Immunity, 2000
- Probiotic Spectra of Lactic Acid Bacteria (LAB)Critical Reviews in Food Science and Nutrition, 1999